<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epidermal <z:e sem="disease" ids="C0027960" disease_type="Neoplastic Process" abbrv="">nevi</z:e> are common congenital <z:mp ids='MP_0001212'>skin lesions</z:mp> with an incidence of 1 in 1,000 people; however, their genetic basis remains elusive </plain></SENT>
<SENT sid="1" pm="."><plain>Germline mutations of the FGF receptor 3 (FGFR3) cause <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0263661" disease_type="Disease or Syndrome" abbrv="">skeletal disorders</z:e> such as <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> and thanatophoric <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, which can be associated with <z:hpo ids='HP_0000956'>acanthosis nigricans</z:hpo> of the skin </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000956'>Acanthosis nigricans</z:hpo> and common epidermal <z:e sem="disease" ids="C0027960" disease_type="Neoplastic Process" abbrv="">nevi</z:e> of the nonorganoid, nonepidermolytic type share some clinical and histological features </plain></SENT>
<SENT sid="3" pm="."><plain>We used a SNaPshot multiplex assay to screen 39 epidermal <z:e sem="disease" ids="C0027960" disease_type="Neoplastic Process" abbrv="">nevi</z:e> of this type of 33 patients for 11 activating FGFR3 point mutations </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, exon 19 of FGFR3 was directly sequenced </plain></SENT>
<SENT sid="5" pm="."><plain>We identified activating FGFR3 mutations, almost exclusively at codon 248 (R248C), in 11 of 33 (33%) patients with nonorganoid, nonepidermolytic epidermal <z:e sem="disease" ids="C0027960" disease_type="Neoplastic Process" abbrv="">nevi</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In 4 of these cases, samples from adjacent histologically <z:mpath ids='MPATH_458'>normal</z:mpath> skin could be analyzed, and FGFR3 mutations were found to be absent </plain></SENT>
<SENT sid="7" pm="."><plain>Our results suggest that a large proportion of epidermal <z:e sem="disease" ids="C0027960" disease_type="Neoplastic Process" abbrv="">nevi</z:e> are caused by a mosaicism of activating FGFR3 mutations in the human epidermis, secondary to a postzygotic mutation in early embryonic development </plain></SENT>
<SENT sid="8" pm="."><plain>The R248C mutation appears to be a hot spot for FGFR3 mutations in epidermal <z:e sem="disease" ids="C0027960" disease_type="Neoplastic Process" abbrv="">nevi</z:e> </plain></SENT>
</text></document>